Dosing guidelines for fluconazole in patients with renal failure
L Cousin, ML Berre, V Launay-Vacher… - Nephrology Dialysis …, 2003 - academic.oup.com
Fluconazole is a widely used drug that inhibits the synthesis of fungal cell membranes [1, 2].
Its elimination is predominantly via renal excretion with most of the dose recovered in urine …
Its elimination is predominantly via renal excretion with most of the dose recovered in urine …
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
…, KS Lee, M Makuuchi, F Souza, MA Le Berre… - The lancet …, 2015 - thelancet.com
Background There is no standard of care for adjuvant therapy for patients with hepatocellular
carcinoma. This trial was designed to assess the efficacy and safety of sorafenib versus …
carcinoma. This trial was designed to assess the efficacy and safety of sorafenib versus …
[HTML][HTML] Nonmetastatic, castration-resistant prostate cancer and survival with darolutamide
…, M Luz, B Alekseev, I Kuss, MA Le Berre… - … England Journal of …, 2020 - Mass Medical Soc
Background Darolutamide is a structurally distinct androgen-receptor inhibitor that is approved
for the treatment of nonmetastatic, castration-resistant prostate cancer. In the planned …
for the treatment of nonmetastatic, castration-resistant prostate cancer. In the planned …
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study—a randomized clinical trial
…, S Choudhri, A Kureishi, MA Le Berre… - Clinical infectious …, 2008 - academic.oup.com
Background . The aim of this study was to show that sequential intravenous and oral
moxifloxacin monotherapy (400 mg once per day) is as efficacious and safe as a combination …
moxifloxacin monotherapy (400 mg once per day) is as efficacious and safe as a combination …
A new multiplex SARS-CoV-2 antigen microarray showed correlation of IgG, IgA, and IgM antibodies from patients with COVID-19 disease severity and maintenance …
ML Berre, T Paulovčáková, CDM Verissimo, S Doyle… - PloS One, 2023 - journals.plos.org
Zoonotic spillover of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to
humans in December 2019 caused the coronavirus disease 2019 (COVID-19) pandemic. …
humans in December 2019 caused the coronavirus disease 2019 (COVID-19) pandemic. …
T cell costimulation blockade blunts pressure overload-induced heart failure
…, D Vignali, F Riva, AM Ormbostad Berre… - Nature …, 2017 - nature.com
Heart failure (HF) is a leading cause of mortality. Inflammation is implicated in HF, yet
clinical trials targeting pro-inflammatory cytokines in HF were unsuccessful, possibly due to …
clinical trials targeting pro-inflammatory cytokines in HF were unsuccessful, possibly due to …
Overall survival (OS) results of phase III ARAMIS study of darolutamide (DARO) added to androgen deprivation therapy (ADT) for nonmetastatic castration-resistant …
…, M Jievaltas, M Luz, B Alekseev, I Kuss, MA Le Berre… - 2020 - ascopubs.org
5514 Background: DARO is a structurally distinct androgen receptor inhibitor with a favorable
safety profile, approved for treating men with nmCRPC after demonstrating significantly …
safety profile, approved for treating men with nmCRPC after demonstrating significantly …
[HTML][HTML] Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the phase III ARAMIS trial
…, M Luz, B Alekseev, I Kuss, MA Le Berre… - European Journal of …, 2021 - Elsevier
Background In the ARAMIS trial, darolutamide plus androgen deprivation therapy (ADT) versus
placebo plus ADT significantly improved metastasis-free survival (MFS), overall survival (…
placebo plus ADT significantly improved metastasis-free survival (MFS), overall survival (…
Effects of exogenous dietary advanced glycation end products on the cross-talk mechanisms linking microbiota to metabolic inflammation
R Mastrocola, D Collotta, G Gaudioso, M Le Berre… - Nutrients, 2020 - mdpi.com
Heat-processed diets contain high amounts of advanced glycation end products (AGEs). Here
we explore the impact of an AGE-enriched diet on markers of metabolic and inflammatory …
we explore the impact of an AGE-enriched diet on markers of metabolic and inflammatory …
STORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular …
…, KS Lee, M Makuuchi, F Souza, MA Le Berre… - 2014 - ascopubs.org
4006^ Background: Sorafenib is a multikinase inhibitor with proven efficacy in unresectable
HCC. We evaluated the efficacy and safety of adjuvant sorafenib for HCC. Methods: Patients …
HCC. We evaluated the efficacy and safety of adjuvant sorafenib for HCC. Methods: Patients …
